Research User EngagementOur research is ultimately aimed at benefiting human health and welfare. During the translational path there will be a range of different beneficiaries and impact types.
Partnerships exist in all of the School's spheres of research and involve mainly the pharmaceutical, biotechnology and life sciences sectors, including global multinationals and UK/overseas SMEs. Over the last three years staff have engaged with over 40 distinct commercial entities with an average 20-25% of our research income gained from commercial partnerships. Impacts arising from our research include employment of highly-skilled individuals, commercialisation of the School's technologies and improved commercial performance of our partners. Research also allows commerce to better understand and improve their own treatment modalities.
Our research (often in conjunction with the service) leads to change in practice guidelines and standards and improvements in clinical training.
Government and public-sector bodies
Our research stimulates policy debate and its implementation by Government and devolved public-sector bodies. It impacts on NHS/professional workforce planning and leads to new service models.
Public interest groups
Public understanding of the School's research and its societal impact stimulates evidence-based debate, for example, patient groups as advocates for change it directs the campaign strategies and public relations of medical charities. It involves both organisations (medical charities, patient groups) and groups of individuals (general public, schools) across small and large (e.g. National Eisteddfod) audiences - See also Public Engagement Pages.
Exemplars of our Research-User Engagement and arising benefits
|ProTide Technology||Medicines Communication|